Member Info for Troutisout1

It's just trying to catch out some weak hands, it's actually more expensive to buy now since the drop in SP, than it was yesterday afternoon...

TRENCH,

The way they issued RNSs for a £38k contract and another for one that won't happen until 2027 suggests they haven't got a lot up their sleeve, together with confirmation from the BB CEO that there is another 12 months to wait there and it doesn't look massively positive. Of course it could go up, I could win the Euromillions tonight, that's the joys of investing. However on today's trades and the SP history over the last year, I reckon the balance of probability rests to the negative.

By the way, weren't you saying the same thing this time last year Laura, before the placing in February which you stated was unexpected, yet the same warnings were said back then.

Really the only difference is the price is now below nominal value, so likely to need a consolidation before or part of any raise.

Trading update towards the end of the month? Like last year. Interims in early March? Like last year....

Laura, they weren't record revenues in 2025, they were less than 2022 revenues, why do you persist in lying?

By the way you can keep deleting the posts, but be careful what you wish for as that could backfire spectacularly, as you are breaking LSE's rules...

I can have £50k in one share that drops 5% and make 80% on a £2k punt, still down on the period though.

What's the point in responding via proxy, when you then get the posts deleted Laura?

Leads to a very confusing BB and probably more off-putting to anyone else looking in.

Your suggestions assume some sort of exclusivity, with OptiMAL and Library that need not be the case. NCI can licence it for their work and several large Pharms can do so alongside that. The deals will be in terms of milestones and royalties later down the line as well as an up front licensing fee. I think there are plenty of options, but a complete buy out is just one small one given the roadmap we have been given. A bid cannot be ruled out, but that is just 'investors best option' for those who are more short term than others. An early bid while welcome will never be at the full price they could command in 12-24 months time.

The sell was reported 2 hours late, it happened at 8.35am and was the reason the SP dropped. The problem here is that even small 150k sells get delayed an hour and over 250k by 2 hours, so looking at trades data to work out the SP movement is a fruitless task.

TRENCH,

I have said I believe there will be a fundraise in Q1, the SP here will be pushed and shoved before that as the vultures that feed these small company fundraises seek a spike to sell into, ask Burt,

Someone following Laura's view would be down hugely, especially if they got caught in the Feb spike before the placing. to turn a blind eye to the pump and dump behaviour makes you as bad as them.

So TRENCH in the last year who has been closer with their view to what investors really want which is an idea which way their investment is going to go?

Until the contrary view is censored by those only wanting a positive view posted. That's a recipe for disaster and seen it many times before as company SPs crumble, but only the rose tinted view is allowed to post.

So it's not 'open' discussion.

Laura censoring all posts that you disagree with won't help you, investors will look for both sides when deciding to invest and there are other forums that people will post on to counter the bunkum that you post as fact.

New Ormy, I once held ten times that amount at higher up (it was over 2% of the Company at the time), SML only owned 50% of Redmoor and I wanted to say I owned 1% of a Cornish Tin mine to my family in Cornwall (note the Tungsten wasn't an attractive factor back then). I lost quite a packet when it dropped from grace but regrouped and spent the next years building back up. I would love to get back to that level, but need a few more million and getting the cash for that takes time and relies heavily on other events. If I don't get there, I am happy with what I have and look forward to some good growth in SML.

HVO perform Human Challenge trials, these intentionally give the patient an active infectious disease, your asthma trial was probably a field trial/study, not quite the same.

Human Challenge trials are not allowed in the US or many countries Worldwide, hence why HVO are World Leaders.

Well thank you to the seller of 1.5m shares a couple of hours ago (reason for the drop in offer), allowed me to pick mine up just now, at a cheaper price.

Well managed another 1m and a 500k purchase, looking at the old RNSs the holes at Pad2 were completed by 20th October, so expect to start seeing more RNSs flow through soon.

TRENCH, the trial was delayed due to the slower recruitment of patients, not a deliberate extension.

As for the CEO obviously the clinical trial is important to them, they as he said need to get a CE mark for their platform, but listening to the 12 minutes before and the bit after, Beyond Blood seem to be pitching their market at Sports athletes, Bio-hackers and Nutritional markets, not really medical. So I will remain sceptical about any developments as a very long way to go yet and Beyond Blood seem to need the clinical trail for validation of their testing eq

TRENCH,

Why when you post a video of the Beyond Blood CEO who states there are 100 patients being tested 8 times over the course of the next year, would you think it has been expanded or that the data is encouraging?

On the clinical trail in the UK (13m10s)

"It's a long process, it will take another year"